Breaking News Instant updates and real-time market news.

RLX

RLX Technology

$0.00 /

+ (+0.00%)

 10:58
01/22/21
 01/22
10:58
 01/22/21
10:58

RLX Technology indicated to open at $22, IPO priced at $12

RLX Technology (RLX) priced 116.5M shares at $12.00, above the $8.00-$10.00 range. Citi acted as lead book running manager for the offering.

  • 22

    Jan

TODAY'S FREE FLY STORIES

Conference/Events
AMN Healthcare management to meet virtually with Sidoti » 10:33
03/01/21
03/01
10:33
03/01/21
10:33
AMN

AMN Healthcare

$73.85 /

+0.96 (+1.32%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMN AMN Healthcare
$73.85 /

+0.96 (+1.32%)

02/22/21 BMO Capital
AMN Healthcare price target raised to $86 from $81 at BMO Capital
02/19/21 Truist
AMN Healthcare price target raised to $95 from $84 at Truist
01/20/21 Truist
AMN Healthcare price target raised to $84 from $78 at Truist
01/19/21 BMO Capital
AMN Healthcare price target raised to $81 from $72 at BMO Capital
AMN AMN Healthcare
$73.85 /

+0.96 (+1.32%)

02/18/21
AMN Healthcare sees Q1 revenue $800M-$820M, consensus $605.28M
02/18/21
AMN Healthcare reports Q4 adjusted EPS $1.00, consensus 89c
01/11/21
AMN Healthcare sees Q4 revenue $623M-$628M, consensus $584.45M
11/05/20
AMN Healthcare sees Q4 revenue $575M-$585M, consensus $549.71M
03/16/21
31st Annual Healthcare Virtual Conference
03/29/21
AMN Healthcare - AMN
03/03/21
AMN Healthcare
Recommendations
InvaGen takeout 'may still be in play' at Avenue, says H.C. Wainwright » 10:32
03/01/21
03/01
10:32
03/01/21
10:32
ATXI

Avenue Therapeutics

$5.00 /

+0.29 (+6.16%)

After Avenue Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ATXI Avenue Therapeutics
$5.00 /

+0.29 (+6.16%)

10:28 Today
Avenue Therapeutics reports PDUFA date of April 12, 2021 set for IV Tramadol
02/17/21
Avenue Therapeutics resubmitted New Drug Application for IV tramadol
12/18/20
Avenue Therapeutics announces publication on teal-world data on NMU of tramadol
12/18/20
Avenue Therapeutics announces publication on tramadol non-medical use
ATXI Avenue Therapeutics
$5.00 /

+0.29 (+6.16%)

02/17/21 Dawson James
Fortress Biotech price target raised to $21 from $16 at Dawson James
10/12/20 H.C. Wainwright
Avenue downgraded to Neutral on merger uncertainty at H.C. Wainwright
10/12/20 H.C. Wainwright
Avenue Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
10/12/20 H.C. Wainwright
H.C. Wainwright cuts Fortress Biotech target to $10 after Avenue's 'bizarre' CRL
ATXI Avenue Therapeutics
$5.00 /

+0.29 (+6.16%)

10/12/20
Fly Intel: Wall Street's top stories for Monday
10/12/20
Fly Intel: Wall Street's top stories at midday
10/12/20
Fly Intel: Pre-market Movers
03/16/21
31st Annual Healthcare Virtual Conference
Hot Stocks
FedEx begins shipping newly approved Covid vaccine on behalf of McKesson » 10:30
03/01/21
03/01
10:30
03/01/21
10:30
FDX

FedEx

$259.43 /

+4.4 (+1.73%)

, MCK

McKesson

$172.80 /

+3.99 (+2.36%)

FedEx Express, a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FDX FedEx
$259.43 /

+4.4 (+1.73%)

01/26/21
FedEx Ground CEO Maier to retire July 31, John Smith to succeed
01/19/21
FedEx Express plans to cut 5,500-6,300 jobs in Europe
12/20/20
Fly Intel: Top five weekend stock stories
12/20/20
FedEx to ship first wave of Moderna COVID-19 vaccines across the U.S.
MCK McKesson
$172.80 /

+3.99 (+2.36%)

12/20/20
Fly Intel: Top five weekend stock stories
12/20/20
FedEx to ship first wave of Moderna COVID-19 vaccines across the U.S.
12/04/20
McKesson, Amgen sign strategic agreement to help improve cancer care
11/19/20
McKesson names Dr. Kevin Baggett as Chief Impact Officer
FDX FedEx
$259.43 /

+4.4 (+1.73%)

01/07/21 Wolfe Research
FedEx downgraded to Peer Perform from Outperform at Wolfe Research
12/30/20 Argus
FedEx price target raised to $305 from $270 at Argus
12/18/20 Raymond James
FedEx price target raised to $305 from $280 at Raymond James
12/18/20 Morgan Stanley
FedEx's 'modest' Q2 beat likely falls short of high bar, says Morgan Stanley
MCK McKesson
$172.80 /

+3.99 (+2.36%)

02/03/21 Credit Suisse
McKesson price target raised to $192 from $178 at Credit Suisse
02/03/21 Deutsche Bank
McKesson price target raised to $231 from $222 at Deutsche Bank
02/03/21 Mizuho
McKesson price target raised to $190 from $178 at Mizuho
02/01/21 Cowen
McKesson price target raised to $210 from $186 at Cowen
FDX FedEx
$259.43 /

+4.4 (+1.73%)

12/17/20
FedEx aims to increase EPS by 10%-15 per year over long term
12/17/20
FedEx reports Q2 EPS $4.83, consensus $4.01
12/17/20
Notable companies reporting after market close
09/15/20
FedEx reports Q1 adjusted EPS $4.87, consensus $2.69
MCK McKesson
$172.80 /

+3.99 (+2.36%)

02/02/21
McKesson raises FY21 adjusted EPS view to $16.95-$17.25 from $16.00-$16.50
02/02/21
McKesson reports Q3 adjusted EPS $4.60, consensus $4.13
02/01/21
Notable companies reporting before tomorrow's open
02/01/21
Notable companies reporting before tomorrow's open
FDX FedEx
$259.43 /

+4.4 (+1.73%)

12/15/20
FedEx, UPS limiting packages they pick up, creating backlogs, WSJ reports
11/25/20
FedEx, UPS run into shortage of vans amid delivery rush, Bloomberg reports
11/10/20
Amazon moving into middle-mile trucking business, The Information reports
10/19/20
FedEx, UPS holiday capacity 'already spoken for,' WSJ reports
MCK McKesson
$172.80 /

+3.99 (+2.36%)

02/16/21
McKesson in talks to sell LloydsPharmacy chain, Sky News reports
01/20/21
McKesson to replace some Moderna vaccine shots shipped too cold, Bloomberg says
11/05/20
Distributors and J&J closing in on $26B opioid settlement deal, NY Times says
09/24/20
U.S. appeals court rejects novel opioid settlement framework, Reuters says
FDX FedEx
$259.43 /

+4.4 (+1.73%)

12/30/20
AstraZeneca upgrade, Spotify target change among top calls on Wall Street
12/18/20
Fly Intel: Wall Street's top stories for Friday
12/18/20
Fly Intel: Wall Street's top stories at midday
12/18/20
Fly Intel: Pre-market Movers
MCK McKesson
$172.80 /

+3.99 (+2.36%)

02/02/21
Fly Intel: Wall Street's top stories for Tuesday
02/02/21
Fly Intel: Wall Street's top stories at midday
02/02/21
Fly Intel: Pre-market Movers
11/24/20
Fly Intel: Wall Street's top stories at midday
03/02/21
41st Annual Healthcare Virtual Conference
03/18/21
FedEx - FDX
FDX FedEx
$259.43 /

+4.4 (+1.73%)

02/05/21
Unusually active option classes on open February 5th
12/17/20
Fedex options imply 9.8% move in share price post-earnings
09/24/20
Unusual call flow in option market yesterday
09/23/20
Fedex puts deliver express profits as shares tumble $6
MCK McKesson
$172.80 /

+3.99 (+2.36%)

11/03/20
Early notable gainers among liquid option names on November 3rd
General news
Treasury Action: yields are mixed despite a hefty rally on Wall Street » 10:30
03/01/21
03/01
10:30
03/01/21
10:30

Treasury Action: yields…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Avenue Therapeutics reports PDUFA date of April 12, 2021 set for IV Tramadol » 10:28
03/01/21
03/01
10:28
03/01/21
10:28
ATXI

Avenue Therapeutics

$5.00 /

+0.29 (+6.16%)

In a regulatory filing…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ATXI Avenue Therapeutics
$5.00 /

+0.29 (+6.16%)

02/17/21
Avenue Therapeutics resubmitted New Drug Application for IV tramadol
12/18/20
Avenue Therapeutics announces publication on teal-world data on NMU of tramadol
12/18/20
Avenue Therapeutics announces publication on tramadol non-medical use
12/17/20
Avenue Therapeutics plans to resubmit NDA for IV tramadol in February 2021
ATXI Avenue Therapeutics
$5.00 /

+0.29 (+6.16%)

02/17/21 Dawson James
Fortress Biotech price target raised to $21 from $16 at Dawson James
10/12/20 H.C. Wainwright
Avenue downgraded to Neutral on merger uncertainty at H.C. Wainwright
10/12/20 H.C. Wainwright
Avenue Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
10/12/20 H.C. Wainwright
H.C. Wainwright cuts Fortress Biotech target to $10 after Avenue's 'bizarre' CRL
ATXI Avenue Therapeutics
$5.00 /

+0.29 (+6.16%)

10/12/20
Fly Intel: Wall Street's top stories for Monday
10/12/20
Fly Intel: Wall Street's top stories at midday
10/12/20
Fly Intel: Pre-market Movers
03/16/21
31st Annual Healthcare Virtual Conference
Conference/Events
Jones Lang LaSalle participates in a conference call with BMO Capital » 10:27
03/01/21
03/01
10:27
03/01/21
10:27
JLL

Jones Lang LaSalle

$178.25 /

+3.765 (+2.16%)

Conference call with Bob…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JLL Jones Lang LaSalle
$178.25 /

+3.765 (+2.16%)

02/17/21
JLL appoints Gilda Perez-Alvarado as global CEO, Hotels & Hospitality
01/25/21
JLL appoints Ingrid Jacobs as head of diversity, inclusion
11/24/20
BP, Jones Lang LaSalle enter multi-year vested workplace evolution agreement
11/20/20
JLL names Rastogi chief product officer to lead JLL Technologies
JLL Jones Lang LaSalle
$178.25 /

+3.765 (+2.16%)

02/26/21 JPMorgan
Jones Lang LaSalle price target raised to $200 from $176 at JPMorgan
01/25/21 Goldman Sachs
Jones Lang LaSalle initiated with a Buy at Goldman Sachs
12/21/20 JPMorgan
Jones Lang LaSalle price target raised to $172 from $132 at JPMorgan
10/07/20 Keefe Bruyette
Jones Lang LaSalle downgraded to Market Perform at Keefe Bruyette
JLL Jones Lang LaSalle
$178.25 /

+3.765 (+2.16%)

02/09/21
Jones Lang LaSalle reports Q4 adjusted EPS $5.29 vs. $6.35 a year ago
02/09/21
Jones Lang LaSalle reports Q4 adjusted EPS $5.29, consensus $3.93
11/02/20
Jones Lang LaSalle reports Q3 adjusted EPS $2.99, consensus $1.25
11/02/20
Jones Lang LaSalle reports Q3 adjusted EPS $2.99, consensus $1.25
00:00 Today
42nd Annual Institutional Investors Virtual Conference
03/03/21
Jones Lang LaSalle - JLL
Options
Macy's call volume above normal and directionally bullish » 10:25
03/01/21
03/01
10:25
03/01/21
10:25
M

Macy's

$16.06 /

+0.86 (+5.66%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
M Macy's
$16.06 /

+0.86 (+5.66%)

02/23/21
Macy's starting the year with 'really healthy' inventory
02/23/21
Macy's sees 1H21 'very similar' to 4Q20
02/23/21
Macy's testing off-mall concepts in Dallas, Atlanta, Washington DC
02/23/21
Macy's to open more Backstage discount concepts in 2021
M Macy's
$16.06 /

+0.86 (+5.66%)

02/24/21 Credit Suisse
Macy's price target raised to $13 from $7 at Credit Suisse
02/24/21 Deutsche Bank
Macy's price target raised to $16 from $15 at Deutsche Bank
02/18/21 Morgan Stanley
Macy's price target raised to $11 from $6 at Morgan Stanley
01/21/21 Deutsche Bank
Macy's price target raised to $15 from $9 at Deutsche Bank
M Macy's
$16.06 /

+0.86 (+5.66%)

02/23/21
Macy's sees Q1 adjusted EPS (52c)-(45c), consensus (29c)
02/23/21
Macy's sees FY21 adjusted EPS 40c-90c, consensus 76c
02/23/21
Macy's reports Q4 adjusted EPS 80c, consensus 12c
02/22/21
Notable companies reporting before tomorrow's open
M Macy's
$16.06 /

+0.86 (+5.66%)

02/28/21
Macy's, Gap letting customers buy now, pay later, WSJ reports
01/05/21
Macy's to close 45 department stores by mid-year, CNBC reports
12/02/20
UPS imposes shipping restrictions on Gap, Nike, WSJ reports
10/14/20
Macy's converts two stores to fulfillment centers, Delaware News says
M Macy's
$16.06 /

+0.86 (+5.66%)

02/23/21
Fly Intel: Wall Street's top stories for Tuesday
02/23/21
Fly Intel: Wall Street's top stories at midday
02/23/21
Fly Intel: Pre-market Movers
12/18/20
Fly Intel: What to watch in Nike's earnings report
M Macy's
$16.06 /

+0.86 (+5.66%)

01/28/21
Macy's call volume above normal and directionally bullish
01/28/21
Early notable gainers among liquid option names on January 28th
01/27/21
Early notable gainers among liquid option names on January 27th
01/25/21
Macy's call volume above normal and directionally bullish
Conference/Events
UBS consumer goods analysts to hold an analyst/industry conference call » 10:25
03/01/21
03/01
10:25
03/01/21
10:25

Consumer Goods Analysts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Vocera to hold virtual investor briefing » 10:25
03/01/21
03/01
10:25
03/01/21
10:25
VCRA

Vocera

$44.04 /

+1.1 (+2.56%)

Virtual Investor Briefing…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VCRA Vocera
$44.04 /

+1.1 (+2.56%)

02/10/21
Vocera falls -10.8%
01/29/21
Vocera CFO Justin Spencer to leave in June
12/18/20
Vocera rises 10.6%
VCRA Vocera
$44.04 /

+1.1 (+2.56%)

02/12/21 Piper Sandler
Piper boosts Vocera target to $56, says buy into March 1 investor day
02/12/21 Baird
Vocera upgraded to Outperform from Neutral at Baird
02/12/21 Craig-Hallum
Vocera price target raised to $50 from $40 at Craig-Hallum
02/12/21 William Blair
Vocera has good visibility into 'solid' 2021, says William Blair
VCRA Vocera
$44.04 /

+1.1 (+2.56%)

02/11/21
Vocera sees FY21 adjusted EPS 45c-61c, consensus 59c
02/11/21
Vocera reports Q4 adjusted EPS 28c, consensus 20c
10/29/20
Vocera reports Q3 EPS 31c, consensus 13c
VCRA Vocera
$44.04 /

+1.1 (+2.56%)

02/11/21
Fly Intel: After-Hours Movers
11:00 Today
Vocera Communications Inc
Conference/Events
e.l.f. Beauty participates in a conference call with JPMorgan » 10:25
03/01/21
03/01
10:25
03/01/21
10:25
ELF

e.l.f. Beauty

$26.45 /

+0.73 (+2.84%)

Beverage, Household &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ELF e.l.f. Beauty
$26.45 /

+0.73 (+2.84%)

02/23/21
GameStop announces resignation of CFO Jim Bell
02/03/21
e.l.f. Beauty CEO: We're really pleased with the quarter
01/22/21
e.l.f. Beauty CEO sells 34.6K shares of common stock
01/07/21
e.l.f. Beauty to replace Brooks Automation in the S&P 600 at open on January 7
ELF e.l.f. Beauty
$26.45 /

+0.73 (+2.84%)

02/04/21
e.l.f. Beauty price target raised to $30 from $25 at Truist
01/20/21 Piper Sandler
e.l.f. Beauty downgraded to Neutral from Overweight at Piper Sandler
10/06/20 Piper Sandler
Piper teen survey shows Snap, Amazon and Apple remain favorites
08/06/20 Truist
e.l.f. Beauty price target raised to $25 from $20 at Truist
ELF e.l.f. Beauty
$26.45 /

+0.73 (+2.84%)

02/03/21
e.l.f. Beauty raises FY21 EPS view to 63c-64c from 59c-63c
02/03/21
e.l.f. Beauty reports Q3 adjusted EPS 22c, consensus 24c
02/03/21
Notable companies reporting after market close
11/04/20
e.l.f. Beauty sees FY22-FY24 net sales up mid-high single digits
ELF e.l.f. Beauty
$26.45 /

+0.73 (+2.84%)

02/03/21
Fly Intel: After-Hours Movers
12/30/20
Fly Intel: After-Hours Movers
11/04/20
Fly Intel: After-Hours Movers
10/06/20
Beyond Meat boosted by Piper Sandler teen survey results
11:00 Today
e.l.f. Beauty - ELF
Conference/Events
JPMorgan transports/logistics analyst to hold analyst/industry conference call » 10:25
03/01/21
03/01
10:25
03/01/21
10:25

Transports &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
UBS technology analyst to hold lan analyst/industry conference call » 10:25
03/01/21
03/01
10:25
03/01/21
10:25

Technology Analyst Arcuri…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Upgrade
BYD upgraded to Buy from Neutral at Goldman Sachs » 10:22
03/01/21
03/01
10:22
03/01/21
10:22
BYDDF

BYD

$0.00 /

+ (+0.00%)

Goldman Sachs analyst Fei…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BYDDF BYD
$0.00 /

+ (+0.00%)

11/09/20 JPMorgan
BYD downgraded to Neutral from Overweight at JPMorgan
09/01/20 Jefferies
BYD upgraded to Buy from Hold at Jefferies
06/04/20 JPMorgan
BYD upgraded to Overweight from Underweight at JPMorgan
04/29/20 Jefferies
BYD A shares upgraded to Buy from Hold at Jefferies
Conference/Events
The Genome Partnership to hold a virtual meeting » 10:21
03/01/21
03/01
10:21
03/01/21
10:21
NSTG

NanoString

$71.00 /

+0.98 (+1.40%)

, TWST

Twist Bioscience

$149.86 /

+12.12 (+8.80%)

, PACB

Pacific Biosciences

$34.91 /

+4.34 (+14.20%)

, QGEN

Qiagen

$49.89 /

-0.16 (-0.32%)

, TXG

10x Genomics

$179.29 /

+1.32 (+0.74%)

, CDXS

Codexis

$23.24 /

+1.06 (+4.78%)

, PKI

PerkinElmer

$128.65 /

+2.46 (+1.95%)

, ILMN

Illumina

$447.82 /

+8.24 (+1.87%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, BNGO

Bionano Genomics

$10.01 /

+0.275 (+2.82%)

Advances in Genome…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NSTG NanoString
$71.00 /

+0.98 (+1.40%)

02/22/21
NanoString announces launch of Whole Transcriptome Atlas
11/17/20
NanoString, OHSU partner on GeoMx-based spatial profiling assays
09/09/20
NanoString announces new GeoMx COVID-19 consortium
TWST Twist Bioscience
$149.86 /

+12.12 (+8.80%)

02/18/21
Twist Bioscience and VCGS in development pact for diagnostic assay
02/03/21
Twist Bioscience announces promotions including Siyuan Chen as CTO
01/19/21
Twist Bioscience enters two licensing agreements with Serotiny, Applied StemCell
01/14/21
Twist Bioscience begins shipping new synthetic RNA reference controls
PACB Pacific Biosciences
$34.91 /

+4.34 (+14.20%)

02/24/21
Children's Mercy Kansas City implements four PacBio Sequel IIe Systems
02/18/21
Pacific Biosciences announces LabCorp's addition of PacBio Sequel II Systems
02/10/21
Pacific Biosciences reports Q4 EPS 40c, consensus 32c
02/10/21
Pacific Biosciences announces $900M investment from SoftBank
QGEN Qiagen
$49.89 /

-0.16 (-0.32%)

02/24/21
Qiagen, Inovio expand collaboration to develop NGS companion diagnostic
02/16/21
Paulson & Co. buys Exxon, exits Qiagen in Q4
02/10/21
Qiagen CEO says will consider potential 'bolt-on acquisitions'
02/09/21
Quidel CEO tells Bloomberg won't enter deal without 'obvious strategic fit'
TXG 10x Genomics
$179.29 /

+1.32 (+0.74%)

02/16/21
Third Point buys Upstart, exits Caesars in Q4
10/05/20
10x Genomics acquires ReadCoor for $350M
09/15/20
10x Genomics shipping Chromium Single Cell Multiome ATAC + Gene Expression
CDXS Codexis
$23.24 /

+1.06 (+4.78%)

01/13/21
Codexis, Tate & Lyle expand relationship to enhance stevia, allulose production
PKI PerkinElmer
$128.65 /

+2.46 (+1.95%)

02/23/21
PerkinElmer launches point of care Covid-19 antigen test for mass screening
02/22/21
PerkinElmer gives update on Valencia Branch Laboratory's accreditation process
02/16/21
Organogenesis appoints David Francisco as CFO
01/14/21
PerkinElmer SARS-CoV-2 RT-PCR assay receives FDA EUA for asymptomatic testing
ILMN Illumina
$447.82 /

+8.24 (+1.87%)

02/19/21
Illumina, University Hospital of Tubingen to evaluate WGS potential
02/08/21
Illumina accelerator invests in nine genomics startups for second global cycle
02/04/21
Illumina announces agreement with Belgian Society of Medical Oncology
01/20/21
Illumina wins patent infringement suit against BGI in U.K.
RHHBY Roche
$0.00 /

+ (+0.00%)

02/26/21
Regeneron announces CHMP recommendation for COVID-19 antibody cocktail
02/24/21
Prothena announces presentation of new preclinical PRX005 data
02/19/21
Atea Pharmaceuticals announces Chugai in-license of AT-527 from Roche
02/12/21
Genentech announces results from four Phase III studies of faricimab
BNGO Bionano Genomics
$10.01 /

+0.275 (+2.82%)

02/22/21
Bionano Genomics announces publication on genome-wide model
02/11/21
Bionano Genomics announces publication on method for optical genome mapping
02/09/21
Bionano Genomics' Saphyr adopted by Canada's largest hospital diagnostic lab
02/02/21
Bionano Genomics announces publication of study on DNA methylation
NSTG NanoString
$71.00 /

+0.98 (+1.40%)

01/11/21 Baird
NanoString price target raised to $70 from $60 at Baird
01/06/21 Cowen
NanoString upgraded to Outperform with $75 target at Cowen
01/06/21 Cowen
NanoString upgraded to Outperform from Market Perform at Cowen
12/02/20 JPMorgan
NanoString price target raised to $60 from $45 at JPMorgan
TWST Twist Bioscience
$149.86 /

+12.12 (+8.80%)

02/05/21 Baird
Twist Bioscience price target raised to $200 from $125 at Baird
02/05/21 JPMorgan
Twist Bioscience downgraded to Underweight from Neutral at JPMorgan
01/04/21 Evercore ISI
Evercore ISI cuts Twist Bioscience to In Line, says new verticals take time
01/04/21 Evercore ISI
Twist Bioscience downgraded to In Line from Outperform at Evercore ISI
PACB Pacific Biosciences
$34.91 /

+4.34 (+14.20%)

02/11/21 Cantor Fitzgerald
Pacific Biosciences price target raised to $62 from $45 at Cantor Fitzgerald
02/11/21 Piper Sandler
Pacific Biosciences upgraded to Overweight from Neutral at Piper Sandler
01/15/21 Piper Sandler
Pacific Biosciences price target raised to $20 from $12 at Piper Sandler
01/12/21 Cantor Fitzgerald
Pacific Biosciences price target raised to $45 from $25 at Cantor Fitzgerald
QGEN Qiagen
$49.89 /

-0.16 (-0.32%)

02/19/21 Berenberg
Qiagen price target raised to EUR 56 from EUR 52 at Berenberg
02/09/21 William Blair
Quidel, Qiagen merger would not make sense, says William Blair
02/09/21 Wells Fargo
Qiagen shares should be sold on latest merger talk, says Wells Fargo
02/09/21 Citi
Merger with Qiagen would benefit Quidel, says Citi
TXG 10x Genomics
$179.29 /

+1.32 (+0.74%)

02/18/21 Cowen
10x Genomics price target raised to $200 from $155 at Cowen
02/18/21 JPMorgan
10x Genomics price target raised to $195 from $160 at JPMorgan
02/18/21 Citi
10x Genomics price target raised to $240 from $195 at Citi
12/16/20 Citi
10x Genomics price target raised to $195 from $165 at Citi
CDXS Codexis
$23.24 /

+1.06 (+4.78%)

06:53 Today Stifel
Codexis initiated with a Buy at Stifel
12/30/20 Benchmark
Codexis price target raised to $29 from $21 at Benchmark
07/15/20 Stephens
Codexis resumed with an Overweight at Stephens
03/10/20 Benchmark
Codexis initiated with a Buy at Benchmark
PKI PerkinElmer
$128.65 /

+2.46 (+1.95%)

02/03/21 Citi
PerkinElmer price target raised to $155 from $150 at Citi
01/07/21 Piper Sandler
Oxford Immunotec downgraded to Neutral from Overweight at Piper Sandler
01/07/21 Wells Fargo
PerkinElmer upgraded to Overweight from Equal Weight at Wells Fargo
01/07/21 Wells Fargo
PerkinElmer upgraded to Overweight from Equal Weight at Wells Fargo
ILMN Illumina
$447.82 /

+8.24 (+1.87%)

02/16/21 BTIG
Illumina price target raised to $570 from $410 at BTIG
02/12/21 Piper Sandler
Illumina price target raised to $510 from $415 at Piper Sandler
02/12/21 Cowen
Illumina price target raised to $460 from $385 at Cowen
12/22/20
Fly Intel: Top five analyst upgrades
RHHBY Roche
$0.00 /

+ (+0.00%)

02/25/21 Berenberg
Roche price target lowered to CHF 320 from CHF 325 at Berenberg
02/24/21 Morgan Stanley
Roche price target lowered to CHF 345 from CHF 365 at Morgan Stanley
02/23/21 BofA
BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list
02/17/21 UBS
UBS downgrades Roche to Neutral on risk to 2022 estimates
BNGO Bionano Genomics
$10.01 /

+0.275 (+2.82%)

02/08/21 Oppenheimer
Bionano Genomics price target raised to $15 from $1.50 at Oppenheimer
01/26/21 Ladenburg
Bionano Genomics price target raised to $14 from $1.25 at Ladenburg
01/22/21 Maxim
Bionano Genomics price target raised to $14 from $2 at Maxim
12/04/20 Roth Capital
Bionano Genomics downgraded to Neutral from Buy at Roth Capital
NSTG NanoString
$71.00 /

+0.98 (+1.40%)

01/10/21
NanoString sees Q4 product/service revenue $35.7M, consensus $33.36M
11/09/20
NanoString reports Q3 EPS (56c), consensus (60c)
10/06/20
NanoString sees Q3 product/service revenue $30.1M, consensus $27.19M
TWST Twist Bioscience
$149.86 /

+12.12 (+8.80%)

02/04/21
Twist Bioscience backs FY21 revenue view $110M-$118M, consensus $116.02M
02/04/21
Twist Bioscience reports Q1 EPS (72c), consensus (74c)
11/23/20
Twist Bioscience sees Q1 revenue $25M-$26M
11/23/20
Twist Bioscience sees FY21 revenue $110M-$118M, consensus $117.9M
PACB Pacific Biosciences
$34.91 /

+4.34 (+14.20%)

01/11/21
Pacific Biosciences sees Q4 revenue $27M, consensus $23.69M
11/02/20
Pacific Biosciences reports Q3 EPS (14c), consensus (13c)
QGEN Qiagen
$49.89 /

-0.16 (-0.32%)

02/09/21
Qiagen backs FY21 EPS view $2.42-$2.46, consensus $2.40
02/09/21
Qiagen reports Q4 EPS 68c, consensus 65c
12/08/20
Qiagen sees FY21 adj. EPS $2.42-$2.46 CER, consensus $2.40
12/08/20
Qiagen raises FY20 adj. EPS view to $2.13-$2.14 CER from $2.07-$2.09 CER
TXG 10x Genomics
$179.29 /

+1.32 (+0.74%)

02/17/21
10x Genomics sees FY21 revenue $480M-$500M, consensus $494.02M
02/17/21
10x Genomics reports Q4 EPS ($3.87), consensus (23c)
11/10/20
10x Genomics reports Q3 EPS (65c), consensus (30c)
CDXS Codexis
$23.24 /

+1.06 (+4.78%)

02/25/21
Codexis sees FY21 revenue $82M-$85M, consensus $80.53M
02/25/21
Codexis reports Q4 EPS (6c), consensus (12c)
11/05/20
Codexis reports Q3 EPS (10c), consensus (11c)
PKI PerkinElmer
$128.65 /

+2.46 (+1.95%)

02/02/21
PerkinElmer sees Q1 adjusted EPS of at least $3.00, consensus $2.40
02/02/21
PerkinElmer sees FY21 adjusted EPS at least $8.50, consensus $8.88
02/02/21
PerkinElmer reports Q4 adjusted EPS $3.96, consensus $3.00
01/11/21
PerkinElmer sees Q4 adjusted EPS 'at least' $3.60, consensus $2.79
ILMN Illumina
$447.82 /

+8.24 (+1.87%)

02/11/21
Illumina sees FY21 adjusted EPS $5.10-$5.35, consensus $6.11
02/11/21
Illumina reports Q4 adjusted EPS $1.22, consensus $1.11
02/11/21
Notable companies reporting after market close
01/11/21
Illumina sees FY21 adjusted EPS $5.10-$5.35, consensus $6.61
RHHBY Roche
$0.00 /

+ (+0.00%)

02/04/21
Roche reports 2020 core EPS CHF 19.16 vs. CHF 20.16 last year
10/27/20
Oncolytics announces new GI cancer study using
10/15/20
Roche confirms outlook for 2020 based on assessment of COVID-19
10/15/20
Roche reports 9 months group sales CHF43.98B vs. CHF46.07B last year
BNGO Bionano Genomics
$10.01 /

+0.275 (+2.82%)

11/12/20
Bionano Genomics reports Q3 revenue $2.2M, consensus $2.07M.
10/15/20
Bionano Genomics sees Q3 revenue $1.9M-$2.3M, consensus $2.07M
  • 20
    Jan
  • 08
    Jan
  • 03
    Dec
  • 03
    Dec
  • 11
    Nov
  • 08
    Oct
  • 11
    Sep
  • 12
    Aug
  • 04
    Jun
PACB Pacific Biosciences
$34.91 /

+4.34 (+14.20%)

02/23/21
Sources claim Softbank plans 'billions' in investment in biotech, Bloomberg says
02/10/21
SoftBank to invest $900M in Pacific Biosciences, WSJ reports
01/08/21
SoftBank has taken 6% stake in Pacific Biosciences, Bloomberg reports
01/08/21
Pacific Biosciences jumps after Bloomberg says SoftBank takes 6% stake
QGEN Qiagen
$49.89 /

-0.16 (-0.32%)

02/08/21
Quidel weighs combining with Qiagen, Bloomberg reports
02/08/21
Qiagen jumps after Bloomberg says Quidel made preliminary approach
02/08/21
Quidel weighs combining with Qiagen, Bloomberg reports
ILMN Illumina
$447.82 /

+8.24 (+1.87%)

09/16/20
Illumina near deal to acquire cancer testing company Grail, Bloomberg reports
RHHBY Roche
$0.00 /

+ (+0.00%)

02/11/21
Roche arthritis drug reduced Covid deaths in study, Reuters reports
12/23/20
Judge rules against White House drug pricing rule, Reuters says
11/23/20
EU seeks easier access to generic medicines, Reuters says
11/20/20
Trump to release new rules aimed at lowering drug prices, WSJ reports
NSTG NanoString
$71.00 /

+0.98 (+1.40%)

10/06/20
Fly Intel: After-Hours Movers
TWST Twist Bioscience
$149.86 /

+12.12 (+8.80%)

02/05/21
Fly Intel: Wall Street's top stories for Friday
02/05/21
Fly Intel: Wall Street's top stories at midday
12/01/20
Fly Intel: After-Hours Movers
11/23/20
Fly Intel: Pre-market Movers
PACB Pacific Biosciences
$34.91 /

+4.34 (+14.20%)

11/03/20
Fly Intel: Pre-market Movers
10/02/20
Fly Intel: Pre-market Movers
QGEN Qiagen
$49.89 /

-0.16 (-0.32%)

02/09/21
Fly Intel: After-Hours Movers
02/08/21
Fly Intel: Wall Street's top stories for Monday
11/11/20
Fly Intel: After-Hours Movers
TXG 10x Genomics
$179.29 /

+1.32 (+0.74%)

10/05/20
Fly Intel: After-Hours Movers
09/08/20
Fly Intel: After-Hours Movers
CDXS Codexis
$23.24 /

+1.06 (+4.78%)

12/03/20
Fly Intel: Wall Street's top stories for Thursday
12/03/20
Fly Intel: Wall Street's top stories at midday
12/03/20
Fly Intel: Pre-market Movers
PKI PerkinElmer
$128.65 /

+2.46 (+1.95%)

01/07/21
Fly Intel: Pre-market Movers
ILMN Illumina
$447.82 /

+8.24 (+1.87%)

10/29/20
Fly Intel: After-Hours Movers
09/21/20
Fly Intel: Wall Street's top stories for Monday
09/21/20
Fly Intel: Wall Street's top stories at midday
09/21/20
Fly Intel: Pre-market Movers
RHHBY Roche
$0.00 /

+ (+0.00%)

12/26/20
Week in review: How Trump's policies moved stocks
11/30/20
Fly Intel: Wall Street's top stories for Monday
11/30/20
Fly Intel: Wall Street's top stories at midday
11/21/20
Week in review: How Trump's policies moved stocks
BNGO Bionano Genomics
$10.01 /

+0.275 (+2.82%)

01/19/21
Fly Intel: After-Hours Movers
01/15/21
Fly Intel: Wall Street's top stories at midday
01/08/21
Fly Intel: Wall Street's top stories for Friday
01/08/21
Fly Intel: Wall Street's top stories at midday
00:00 Today
Advances in Genome Biology & Technology: AGBT 2021 Virtual Event
03/02/21
41st Annual Healthcare Virtual Conference
03/02/21
2021 London Global Healthcare Virtual Conference
03/15/21
33rd Annual Roth Virtual Conference
03/16/21
31st Annual Healthcare Virtual Conference
16:30 Today
NanoString - NSTG
03/25/21
Roche - RHHBY
PACB Pacific Biosciences
$34.91 /

+4.34 (+14.20%)

01/08/21
Pacific Biosciences call volume above normal and directionally bullish
11/02/20
Pacific Biosciences options imply 18.3% move in share price post-earnings
QGEN Qiagen
$49.89 /

-0.16 (-0.32%)

10/14/20
Call spread buyer crosses wide spread in Qiagen
09/16/20
Largest borrow rate increases among liquid names
PKI PerkinElmer
$128.65 /

+2.46 (+1.95%)

09/11/20
Early notable gainers among liquid option names on September 11th
ILMN Illumina
$447.82 /

+8.24 (+1.87%)

02/12/21
Early notable gainers among liquid option names on February 12th
01/15/21
Early notable gainers among liquid option names on January 15th
12/22/20
Early notable gainers among liquid option names on December 22nd
09/22/20
Illumina call volume above normal and directionally bullish
BNGO Bionano Genomics
$10.01 /

+0.275 (+2.82%)

02/12/21
Bionano Genomics call volume above normal and directionally bullish
02/11/21
Bionano Genomics call volume above normal and directionally bullish
01/26/21
Largest borrow rate increases among liquid names
01/13/21
Thirteen new option listings and two option delistings on January 13th
Downgrade
RBC downgrades Ontrak to Sector Perform, cuts target to $32 after loss of Aetna » 10:21
03/01/21
03/01
10:21
03/01/21
10:21
OTRK

Ontrak

$32.45 /

-26.68 (-45.12%)

, CVS

CVS Health

$68.88 /

+0.75 (+1.10%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OTRK Ontrak
$32.45 /

-26.68 (-45.12%)

10/29/20
Ontrak acquires behavior change platform LifeDojo
10/13/20
Ontrak rises after announcing launch of Ontrak-CI program
CVS CVS Health
$68.88 /

+0.75 (+1.10%)

02/24/21
CVS Health to administer COVID-19 vaccines in six additional states
02/18/21
Capital Senior Living completes first round of COVID-19 vaccinations
02/16/21
CVS has capacity to administer 20M-25M Covid vaccines per month
02/16/21
CVS Health sees Q1 as lowest earnings quarter for the year
OTRK Ontrak
$32.45 /

-26.68 (-45.12%)

10:17 Today RBC Capital
Ontrak downgraded to Sector Perform from Outperform at RBC Capital
01/05/21 Benchmark
GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021
01/04/21 B. Riley Securities
Ontrak price target raised to $110 from $100 at B. Riley Securities
11/18/20 B. Riley Securities
Ontrak initiated with a Buy at B. Riley Securities
CVS CVS Health
$68.88 /

+0.75 (+1.10%)

01/29/21 Jefferies
Carvana, Walmart among 13 additions to Jefferies Franchise Picks list
01/22/21 Baird
Tabula Rasa HealthCare may have lost MTM deal at Aetna, says Baird
01/19/21 JPMorgan
Teladoc remains top 2021 healthcare technology pick at JPMorgan
01/08/21
Fly Intel: Top five analyst upgrades
OTRK Ontrak
$32.45 /

-26.68 (-45.12%)

08:07 Today
Ontrak sees FY21 revenue $100M, consensus $165.05M
08:06 Today
Ontrak reports Q4 EPS (7c), consensus (30c)
11/05/20
Ontrak reports Q3 EPS (36c), consensus (35c)
CVS CVS Health
$68.88 /

+0.75 (+1.10%)

02/16/21
CVS Health sees FY21 revenue $276.1B-$280.6B, consensus $278.39B
02/16/21
CVS Health sees FY21 adjusted EPS $7.39-$7.55, consensus $7.54
02/16/21
CVS Health reports Q4 adjusted EPS $1.30, consensus $1.24
11/06/20
CVS Health raises FY20 adj. EPS view to $7.35-$7.45 from $7.14-$7.27
CVS CVS Health
$68.88 /

+0.75 (+1.10%)

02/14/21
Walmart COVID vaccine rollout heading to small towns, WSJ reports
02/11/21
CVS, Walmart to decide who gets leftover vaccine doses, WSJ reports
01/02/21
Coca-Cola, Disney among value stocks deserving a fresh look, Barron's says
12/20/20
CDC panel says frontline workers, people over 74 should be next, NYTimes reports
CVS CVS Health
$68.88 /

+0.75 (+1.10%)

02/16/21
Fly Intel: Wall Street's top stories at midday
02/16/21
Fly Intel: Pre-market Movers
12/01/20
Fly Intel: What to watch in Salesforce's earnings report
11/17/20
Fly Intel: Wall Street's top stories at midday
03/02/21
41st Annual Healthcare Virtual Conference
03/09/21
Ontrak - OTRK
OTRK Ontrak
$32.45 /

-26.68 (-45.12%)

10/12/20
Largest borrow rate increases among liquid names
09/16/20
Ontrak put volume heavy and directionally bearish
09/15/20
Ontrak put volume heavy and directionally bearish
CVS CVS Health
$68.88 /

+0.75 (+1.10%)

02/16/21
Unusually active option classes on open February 16th
01/11/21
CVS Health call volume above normal and directionally bullish
11/17/20
Unusually active option classes on open November 17th
11/10/20
CVS Health call volume above normal and directionally bullish
Recommendations
Homology Medicines loses potential source of upside, says Oppenheimer » 10:18
03/01/21
03/01
10:18
03/01/21
10:18
FIXX

Homology Medicines

$11.03 /

+0.28 (+2.60%)

, NVS

Novartis

$86.59 /

+0.57 (+0.66%)

Oppenheimer analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FIXX Homology Medicines
$11.03 /

+0.28 (+2.60%)

07:50 Today
Homology Medicines regains worldwide rights to ophthalmology program
02/08/21
Homology reports first presentation of data from IND-enabling studies of HMI-203
01/12/21
Pfizer invests $120M in four clinical-stage biotech companies
01/06/21
Homology Medicines announces plans for three clinical programs in 2021
NVS Novartis
$86.59 /

+0.57 (+0.66%)

07:50 Today
Homology Medicines regains worldwide rights to ophthalmology program
02/17/21
Novartis announces SCD grant agreement with Bill & Melinda Gates Foundation
02/16/21
Novartis reports Entresto granted expanded indication in chronic heart failure
02/11/21
Novartis' Sandoz agrees to acquire GSK's cephalosporin antibiotics business
FIXX Homology Medicines
$11.03 /

+0.28 (+2.60%)

12/14/20 H.C. Wainwright
Homology Medicines transferred with Buy, $30 target at H.C. Wainwright
11/08/20 Oppenheimer
Homology Medicines selloff unjustified in wake of clinical PoC, says Oppenheimer
08/11/20 Oppenheimer
Homology Medicines price target lowered to $27 from $32 at Oppenheimer
08/11/20 H.C. Wainwright
Homology Medicines price target lowered to $30 from $37 at H.C. Wainwright
NVS Novartis
$86.59 /

+0.57 (+0.66%)

02/02/21 Morgan Stanley
Novartis price target lowered to CHF 102 from CHF 104 at Morgan Stanley
02/01/21 Truist
iRhythm price target lowered to $220 from $265 at Truist
02/01/21 Cowen
Novartis downgraded to Market Perform after 'tepid' guidance at Cowen
02/01/21 Cowen
Novartis downgraded to Market Perform from Outperform at Cowen
FIXX Homology Medicines
$11.03 /

+0.28 (+2.60%)

11/09/20
Homology Medicines reports Q 3EPS (62c), consensus (80c)
NVS Novartis
$86.59 /

+0.57 (+0.66%)

01/26/21
Novartis sees 2021 core operating income to grow mid single digit
01/26/21
Novartis reports Q4 core EPS $1.34, consensus $1.36
11/05/20
Xoma reports Q3 EPS (10c), consensus (21c)
10/27/20
Novartis raises FY20 core operating income growth outlook
NVS Novartis
$86.59 /

+0.57 (+0.66%)

12/23/20
Judge rules against White House drug pricing rule, Reuters says
11/23/20
EU seeks easier access to generic medicines, Reuters says
11/20/20
Trump to release new rules aimed at lowering drug prices, WSJ reports
FIXX Homology Medicines
$11.03 /

+0.28 (+2.60%)

11/19/20
Fly Intel: After-Hours Movers
NVS Novartis
$86.59 /

+0.57 (+0.66%)

02/11/21
Fly Intel: Wall Street's top stories for Thursday
02/11/21
Fly Intel: Wall Street's top stories at midday
02/11/21
Fly Intel: Pre-market Movers
12/26/20
Week in review: How Trump's policies moved stocks
03/02/21
41st Annual Healthcare Virtual Conference
03/16/21
31st Annual Healthcare Virtual Conference
Technical Analysis
NASDAQ market internals summary » 10:17
03/01/21
03/01
10:17
03/01/21
10:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
$0.00 /

+ (+0.00%)

02/26/21
NASDAQ market internals summary
02/26/21
NASDAQ market internals summary
02/26/21
NASDAQ market internals summary
02/26/21
NASDAQ market internals summary
Downgrade
Ontrak downgraded to Sector Perform from Outperform at RBC Capital » 10:17
03/01/21
03/01
10:17
03/01/21
10:17
OTRK

Ontrak

$32.50 /

-26.63 (-45.04%)

RBC Capital analyst Sean…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OTRK Ontrak
$32.50 /

-26.63 (-45.04%)

10/29/20
Ontrak acquires behavior change platform LifeDojo
10/13/20
Ontrak rises after announcing launch of Ontrak-CI program
OTRK Ontrak
$32.50 /

-26.63 (-45.04%)

01/05/21 Benchmark
GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021
01/04/21 B. Riley Securities
Ontrak price target raised to $110 from $100 at B. Riley Securities
11/18/20 B. Riley Securities
Ontrak initiated with a Buy at B. Riley Securities
10/02/20 Canaccord
Ontrak analysis points to significant upside for shares, says Canaccord
OTRK Ontrak
$32.50 /

-26.63 (-45.04%)

08:07 Today
Ontrak sees FY21 revenue $100M, consensus $165.05M
08:06 Today
Ontrak reports Q4 EPS (7c), consensus (30c)
11/05/20
Ontrak reports Q3 EPS (36c), consensus (35c)
03/02/21
41st Annual Healthcare Virtual Conference
03/09/21
Ontrak - OTRK
OTRK Ontrak
$32.50 /

-26.63 (-45.04%)

10/12/20
Largest borrow rate increases among liquid names
09/16/20
Ontrak put volume heavy and directionally bearish
09/15/20
Ontrak put volume heavy and directionally bearish
Hot Stocks
Workhorse Group has scheduled a face-to-face meeting with USPS on March 3 » 10:16
03/01/21
03/01
10:16
03/01/21
10:16
WKHS

Workhorse Group

$15.96 /

-0.23 (-1.42%)

Comments taken from Q4…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WKHS Workhorse Group
$15.96 /

-0.23 (-1.42%)

09:04 Today
Workhorse Group CEO says entering 2021 in 'strongest-ever position'
02/25/21
Workhorse up 20% after congressman vows to fight Oshkosh award from USPS
02/25/21
Workhorse Group trading resumes
02/25/21
Workhorse Group trading halted, volatility trading pause
WKHS Workhorse Group
$15.96 /

-0.23 (-1.42%)

02/24/21
Fly Intel: Top five analyst downgrades
02/24/21 Oppenheimer
Opco downgrades Workhorse after Postal Service snub despite backlog
02/24/21 Roth Capital
Roth cuts Workhorse target to $15 after 'highly unusual' contract loss
02/24/21 Oppenheimer
Workhorse Group downgraded to Perform from Outperform at Oppenheimer
WKHS Workhorse Group
$15.96 /

-0.23 (-1.42%)

09:03 Today
Workhorse Group reports Q4 revenue $652,000, consensus $1.32M
11/09/20
Workhorse Group reports Q3 revenue $565,000, consensus $1.81M
11/09/20
Workhorse Group reports Q3 revenue $565,000, consensus $1.81M
WKHS Workhorse Group
$15.96 /

-0.23 (-1.42%)

02/25/21
House Democrat vows to stop USPS contract with Oshkosh, Bloomberg says
02/01/21
Robinhood in talks with lenders to raise $1B in debt, Reuters reports
01/19/21
Amazon and Ford backed EV Truck-maker Rivian raises another $2.65B, WSJ says
12/02/20
USPS again delays mail truck replacement contract, Trucks.com reports
WKHS Workhorse Group
$15.96 /

-0.23 (-1.42%)

02/27/21
Charged: Tesla temporarily halts Model 3 line at CA plant
02/24/21
Fly Intel: Wall Street's top stories for Wednesday
02/24/21
Fly Intel: Wall Street's top stories at midday
02/24/21
Workhorse plunges, asks USPS for more info after NGDV deal goes to Oshkosh
10:00 Today
Workhorse Group - WKHS
WKHS Workhorse Group
$15.96 /

-0.23 (-1.42%)

02/04/21
Workhorse Group call volume above normal and directionally bullish
01/28/21
Largest borrow rate increases among liquid names
01/26/21
Workhorse Group call volume above normal and directionally bullish
01/26/21
Unusually active option classes on open January 26th
Technical Analysis
NYSE market internals summary » 10:16
03/01/21
03/01
10:16
03/01/21
10:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
$0.00 /

+ (+0.00%)

02/26/21
NYSE market internals summary
02/26/21
NYSE market internals summary
02/26/21
NYSE market internals summary
02/26/21
NYSE market internals summary
General news
U.S. February ISM manufacturing index increased 2.1 points to 60.8 » 10:15
03/01/21
03/01
10:15
03/01/21
10:15

U.S. February ISM…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
FX Action: The dollar » 10:15
03/01/21
03/01
10:15
03/01/21
10:15

FX Action: The dollar…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
U.S. construction spending surged 1.7% in January » 10:15
03/01/21
03/01
10:15
03/01/21
10:15

U.S. construction…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Options
Sallie Mae put volume heavy and directionally bearish » 10:15
03/01/21
03/01
10:15
03/01/21
10:15
SLM

Sallie Mae

$15.99 /

+0.22 (+1.40%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SLM Sallie Mae
$15.99 /

+0.22 (+1.40%)

02/25/21
Sallie Mae increases price range, extends expiration to buy up to $1B in stock
01/26/21
Sallie Mae names Kerri Palmer Chief Risk and Compliance Officer
SLM Sallie Mae
$15.99 /

+0.22 (+1.40%)

01/29/21 Barclays
Sallie Mae price target raised to $18 from $15 at Barclays
01/29/21 RBC Capital
Sallie Mae upgraded to Outperform from Sector Perform at RBC Capital
01/29/21 Citi
Sallie Mae price target raised to $16 from $12 at Citi
01/29/21 RBC Capital
Sallie Mae upgraded to Outperform from Sector Perform at RBC Capital
SLM Sallie Mae
$15.99 /

+0.22 (+1.40%)

01/27/21
Sallie Mae reports Q4 core EPS $1.15, consensus 35c
01/27/21
Notable companies reporting after market close
10/21/20
Sallie Mae reports Q3 core EPS 47c, consensus 8c
10/21/20
Notable companies reporting after market close
SLM Sallie Mae
$15.99 /

+0.22 (+1.40%)

02/22/21
Fly Insider: Corvus, ALJ Regional Holdings among week's notable insider trades
01/27/21
Fly Intel: After-Hours Movers
10/21/20
Fly Intel: After-Hours Movers
SLM Sallie Mae
$15.99 /

+0.22 (+1.40%)

01/27/21
Sallie Mae put volume heavy and directionally bearish
12/14/20
Unusual call flow in option market yesterday
Periodicals
Goldman co-head of asset management leaving firm, Bloomberg reports » 10:13
03/01/21
03/01
10:13
03/01/21
10:13
GS

Goldman Sachs

$323.85 /

+6.66 (+2.10%)

Eric Lane, the Global…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GS Goldman Sachs
$323.85 /

+6.66 (+2.10%)

02/19/21
Goldman Sachs CFO sells 20K shares of common stock
02/02/21
Goldman Sachs officer Laurence Stein sold almost $3M in company shares
02/01/21
Northrop Grumman announces $2B accelerated share repurchase program
01/19/21
Goldman Sachs: Investment banking backlog at near-record levels
GS Goldman Sachs
$323.85 /

+6.66 (+2.10%)

02/24/21 Wells Fargo
Goldman Sachs price target raised to $360 from $335 at Wells Fargo
01/28/21 Deutsche Bank
Goldman Sachs price target raised to $310 from $290 at Deutsche Bank
01/22/21 Citi
Goldman Sachs price target raised to $370 from $357 at Citi
01/20/21 Credit Suisse
Goldman Sachs price target raised to $345 from $325 at Credit Suisse
GS Goldman Sachs
$323.85 /

+6.66 (+2.10%)

01/19/21
Goldman Sachs reports Q4 EPS $12.08, consensus $7.47
01/18/21
Fly Intel: What to watch in next round of big banks' earnings reports
10/14/20
Goldman Sachs reports Q3 EPS $9.68, consensus $5.57
10/13/20
Notable companies reporting before tomorrow's open
GS Goldman Sachs
$323.85 /

+6.66 (+2.10%)

06:24 Today
Goldman's Omer Ismail leaving to run Walmart's fintech startup, WSJ reports
02/22/21
Toast planning IPO that could value it at around $20B, WSJ reports
02/16/21
Goldman Sachs set to unveil Marcus Invest, WSJ reports
02/03/21
USA Rare Earth exploring New York listing, WSJ reports
GS Goldman Sachs
$323.85 /

+6.66 (+2.10%)

02/05/21
The Intersection: Crypto and Wall Street This Week
01/21/21
Fly Intel: What to watch in IBM's earnings report
01/19/21
Fly Intel: Wall Street's top stories at midday
01/19/21
Fly Intel: Pre-market Movers
03/25/21
REITwise 2021 Virtual Conference
04/14/21
Goldman Sachs - GS
09:00 Today
Culture/Session 3: Diversity, Equity & Inclusion
GS Goldman Sachs
$323.85 /

+6.66 (+2.10%)

01/13/21
Unusual call flow in option market yesterday
01/12/21
Short term 300 strike calls in Goldman Sachs see early action
01/07/21
Goldman Sachs call volume above normal and directionally bullish
12/23/20
Unusually active option classes on open December 23rd

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.